Literature DB >> 9488418

Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.

V Rodrigues1, J Santana da Silva, A Campos-Neto.   

Abstract

Hamsters infected with Leishmania donovani develop a disease similar to human kala-azar. They present hypergammaglobulinemia, and their T cells do not respond to parasite antigens. This unresponsiveness has been primarily ascribed to defects in antigen-presenting cells (APCs), because these cells are unable to stimulate proliferation of parasite-specific T cells from immunized animals. In this study, we show that APCs (adherent spleen cells) from L. donovani-infected hamsters produce high levels of the inhibitory cytokine transforming growth factor beta (TGF-beta). Immunohistochemical studies with an anti-TGF-beta monoclonal antibody (MAb) showed that this cytokine is abundantly produced in vivo by the spleen cells of infected animals. In addition, high levels of TGF-beta are produced in vitro by infected hamster cells, either spontaneously or after stimulation with parasite antigen or lipopolysaccharide. Furthermore, in vivo-infected adherent cells obtained from spleens of L. donovani-infected hamsters caused profound inhibition of the in vitro antigen-induced proliferative response of lymph node cells from hamsters immunized with leishmanial antigens. Moreover, this inhibition was totally abrogated by the anti-TGF-beta MAb. These results suggest that the immunosuppression observed in visceral leishmaniasis is, at least in part, due to the abundant production of TGF-beta during the course of the infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488418      PMCID: PMC108038          DOI: 10.1128/IAI.66.3.1233-1236.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

Authors:  A Ding; C F Nathan; J Graycar; R Derynck; D J Stuehr; S Srimal
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

2.  Immune complex glomerulonephritis in experimental kala-azar.

Authors:  A Sartori; A V De Oliveira; M C Roque-Barreira; M A Rossi; A Campos-Neto
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

3.  Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.

Authors:  V Rodrigues Júnior; J S Da Silva; A Campos-Neto
Journal:  Parasite Immunol       Date:  1992-01       Impact factor: 2.280

4.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

5.  Deactivation of macrophages by transforming growth factor-beta.

Authors:  S Tsunawaki; M Sporn; A Ding; C Nathan
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

6.  Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

Authors:  A Barral; M Barral-Netto; E C Yong; C E Brownell; D R Twardzik; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 7.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Leishmania major interferes with antigen presentation by infected macrophages.

Authors:  U Fruth; N Solioz; J A Louis
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

9.  Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages.

Authors:  J A López; J H LeBowitz; S M Beverley; H G Rammensee; P Overath
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

10.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Authors:  J H Kehrl; A B Roberts; L M Wakefield; S Jakowlew; M B Sporn; A S Fauci
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

View more
  21 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Role for nitric oxide in hookworm-associated immune suppression.

Authors:  Blaise Dondji; Richard D Bungiro; Lisa M Harrison; Jon J Vermeire; Carlo Bifulco; Diane McMahon-Pratt; Michael Cappello
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

3.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibody.

Authors:  Ananda Mookerjee; Parimal C Sen; Asoke C Ghose
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi.

Authors:  N Gomez-Escobar; W F Gregory; R M Maizels
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 6.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

7.  Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responses.

Authors:  S Kansal; R Tandon; A Verma; P Misra; A K Choudhary; R Verma; P R P Verma; A Dube; P R Mishra
Journal:  Br J Pharmacol       Date:  2014-07-25       Impact factor: 8.739

Review 8.  Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fernanda N Araujo; Ariane F Leal; Christiane Y Ozaki; Orlando R Sevillano; Bernardina A Uscata; Hiro Goto
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

9.  Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.

Authors:  Nádia das Dores Moreira; Juliana Vitoriano-Souza; Bruno Mendes Roatt; Paula Melo de Abreu Vieira; Henrique Gama Ker; Jamille Mirelle de Oliveira Cardoso; Rodolfo Cordeiro Giunchetti; Cláudia Martins Carneiro; Marta de Lana; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.

Authors:  Anupam Adhikari; Gaurav Gupta; Saikat Majumder; Sayantan Banerjee; Surajit Bhattacharjee; Parna Bhattacharya; Sangeeta Kumari; Subhadra Haldar; Suchandra Bhattacharyya Majumdar; Bhaskar Saha; Subrata Majumdar
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.